Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Cash from Investing Activities (2016 - 2025)

AtriCure (ATRC) has disclosed Cash from Investing Activities for 16 consecutive years, with -$2.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 82.29% to -$2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$14.6 million, a 148.12% decrease, with the full-year FY2025 number at -$14.6 million, down 148.12% from a year prior.
  • Cash from Investing Activities was -$2.6 million for Q4 2025 at AtriCure, roughly flat from -$2.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $63.6 million in Q1 2021 to a low of -$25.1 million in Q3 2021.
  • A 5-year average of $5.3 million and a median of -$302000.0 in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: soared 550.14% in 2022, then plummeted 427.39% in 2024.
  • AtriCure's Cash from Investing Activities stood at $1.1 million in 2021, then skyrocketed by 550.14% to $7.0 million in 2022, then tumbled by 139.79% to -$2.8 million in 2023, then tumbled by 427.39% to -$14.7 million in 2024, then skyrocketed by 82.29% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Cash from Investing Activities are -$2.6 million (Q4 2025), -$2.6 million (Q3 2025), and -$7.7 million (Q2 2025).